Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹12.15
▼ 0.04
(0.30%)
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Divis Laboratories Ltd | 31 Aug 2026 | 10.55% | 45,227 | ₹42.82 Cr | Equity | Pharmaceuticals | |
 Sun Pharmaceutical ... | 31 Aug 2026 | 8.21% | 1,67,824 | ₹33.31 Cr | Equity | Pharmaceuticals | |
 Rubicon Research Ltd | 31 Aug 2026 | 6.81% | 1,51,995 | ₹27.66 Cr | Equity | Pharmaceuticals | |
 Piramal Pharma Ltd | 31 Aug 2026 | 6.72% | 12,71,805 | ₹27.27 Cr | Equity | Pharmaceuticals | |
 Aurobindo Pharma Ltd | 31 Aug 2026 | 6.18% | 1,46,132 | ₹25.09 Cr | Equity | Pharmaceuticals | |
| Apollo Hospitals En... | 31 Aug 2026 | 6.00% | 27,355 | ₹24.34 Cr | Equity | Healthcare | |
 Torrent Pharmaceuti... | 31 Aug 2026 | 5.03% | 40,333 | ₹20.43 Cr | Equity | Pharmaceuticals | |
 Neuland Laboratorie... | 31 Aug 2026 | 4.11% | 7,242 | ₹16.66 Cr | Equity | Pharmaceuticals | |
 Emcure Pharmaceutic... | 31 Aug 2026 | 3.84% | 84,054 | ₹15.59 Cr | Equity | Pharmaceuticals | |
 Max Healthcare Inst... | 31 Aug 2026 | 3.35% | 1,30,366 | ₹13.59 Cr | Equity | Healthcare |
Funds in the same category by AUM
You can invest in Bajaj Finserv Healthcare Fund - Direct (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹500 and the minimum SIP amount is ₹500.
The latest NAV of Bajaj Finserv Healthcare Fund - Direct (G) is ₹12.15.
Bajaj Finserv Healthcare Fund - Direct (G) manages assets worth ₹405.91 Cr.
The expense ratio of Bajaj Finserv Healthcare Fund - Direct (G) is 0.90%.
The exit load applicable on Bajaj Finserv Healthcare Fund - Direct (G) is If units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. If units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable..
As per the riskometer, Bajaj Finserv Healthcare Fund - Direct (G) carries Very High risk.
Bajaj Finserv Healthcare Fund - Direct (G) is managed by Bajaj Finserv Mutual Fund.
Bajaj Finserv Healthcare Fund - Direct (G) belongs to the Sectoral Fund category.
Bajaj Finserv Healthcare Fund - Direct (G) is benchmarked against the BSE Healthcare TRI.
Bajaj Finserv Healthcare Fund - Direct (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
Bajaj Finserv Healthcare Fund - Direct (G) was launched on 27 Dec 2024.
After the initial investment, you can invest in Bajaj Finserv Healthcare Fund - Direct (G) in further multiples of ₹100.
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.
27 Dec 2024
₹405.91 Cr
₹12.15
₹500
₹500
Very High
0.90%
12.32
0.76
0.50
4.88
0.62
0.16
0.80
If units are redeemed / switched out within 3 months from the date of allotment: 1% of applicable NAV. If units are redeemed/switched out after 3 months from the date of allotment, no exit load is payable.
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 Mirae Asset Healthcare Fund -... | 22.11% | 24.02% | 0.61% | ₹3,555.18 Cr | 16.80 | 1.10 | Very High | |
 Aditya Birla SL Pharma & Heal... | 19.32% | 22.43% | 1.02% | ₹1,102.73 Cr | 16.00 | 1.10 | Very High | |
 WhiteOak Capital Pharma and H... | 24.81% | — | 1.13% | ₹902.24 Cr | 19.86 | 1.14 | Very High | |
 | 13.71% | — | 1.56% | ₹507.42 Cr | 8.69 | 0.33 | Very High | |
| Bajaj Finserv Healthcare Fund... | 23.48% | — | 0.90% | ₹405.91 Cr | 12.32 | 0.50 | Very High | |
 ITI Pharma and Healthcare Fun... | 14.94% | 21.48% | 0.92% | ₹276.23 Cr | 0.10 | 0.94 | Very High | |
 PGIM India Healthcare Fund - ... | 26.89% | — | 0.93% | ₹125.15 Cr | 13.84 | 0.59 | Very High |
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
 Cipla Ltd | Pharmaceuticals -... | Bought | 31 Aug 2026 | 1.39% | ₹5.64 Cr | 40,000 | Equity | EQUITY | |
| Neogen Chemicals Ltd | Chemicals - Speci... | Bought | 31 Aug 2026 | 0.21% | ₹0.85 Cr | 3,854 | Equity | EQUITY | |
| Dr Reddys Laborator... | Pharmaceuticals -... | Bought | 31 Jul 2026 | 1.37% | ₹5.17 Cr | 45,000 | Equity | EQUITY | |
 OneSource Specialty... | Biotechnology | Bought | 31 Jul 2026 | 0.95% | ₹3.56 Cr | 22,000 | Equity | EQUITY | |
| Sumitomo Chemical I... | Pesticides / Agro... | Bought | 31 Jul 2026 | 0.27% | ₹1.02 Cr | 20,000 | Equity | EQUITY | |
| Abbott India Ltd | Pharmaceuticals -... | Sold | 30 Jun 2026 | 1.25% | ₹4.42 Cr | 1,738 | Equity | EQUITY | |
| Medplus Health Serv... | Trading - Medium ... | Sold | 30 Jun 2026 | 1.18% | ₹4.19 Cr | 51,652 | Equity | EQUITY | |
| ERIS Lifesciences Ltd | Pharmaceuticals -... | Sold | 30 Jun 2026 | 1.01% | ₹3.58 Cr | 25,000 | Equity | EQUITY | |
| Astrazeneca Pharma ... | Pharmaceuticals -... | Sold | 30 Jun 2026 | 0.76% | ₹2.69 Cr | 3,267 | Equity | EQUITY |
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 ICICI Pru Technology Fund... | ICICI Prudential Mutual Fund | ₹194.12 | ₹13,660.98 Cr | 1.22% | -11.08% | 4.46% | 1.93% | |
 HDFC Defence Fund - Direc... | HDFC Mutual Fund | ₹31.08 | ₹11,477.59 Cr | 0.89% | 23.83% | 38.03% | — | |
| ICICI Pru Banking & Finan... | ICICI Prudential Mutual Fund | ₹145.07 | ₹11,330.58 Cr | 1.23% | -3.67% | 9.21% | 8.98% | |
 SBI Banking & Financial S... | SBI Mutual Fund | ₹47.70 | ₹10,872.95 Cr | 1.20% | -0.70% | 14.93% | 11.76% | |
 Tata Digital India Fund -... | Tata Mutual Fund | ₹46.47 | ₹10,322.02 Cr | 0.67% | -13.66% | 3.50% | 1.77% | |
| Bajaj Finserv Healthcare ... | Bajaj Finserv Mutual Fund | ₹12.15 | ₹405.91 Cr | 0.90% | 23.48% | — | — |